Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2004, p. 6968-6976, Vol. 70, No. 12
0099-2240/04/$08.00+0 DOI: 10.1128/AEM.70.12.6968-6976.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Biological Sciences, Korea Advanced Institute of Science and Technology,1 National Research Laboratory for Microbial Display, GenoFocus Inc., Daeduk BioCommunity, Daejeon, Republic of Korea2
Received 20 May 2004/ Accepted 17 July 2004
|
|
|---|
|
|
|---|
Autotransporters are virulence-related proteins of gram-negative bacteria. Members of the autotransporter family are featured by three domains: the signal sequence, the passenger domain, and the translocator domain (10). An N-terminal signal sequence directs the polypeptide through the Sec apparatus and into the periplasm. The translocator domain consists of a short linking region having an
-helical secondary structure and a ß-domain that integrates into the outer membrane and forms a central hydrophilic pore, allowing the internal passenger domain to be presented on the bacterial surface (16). Generally, the ß-domain of autotransporters is about 250 to 300 amino acid residues in length and exhibits 14 antiparallel amphipathic ß-strands that make up the ß-barrel structure in the outer membrane (10). The passenger domain confers the diverse effector functions to the autotransporters. This passenger domain may stay attached to the cell surface, anchored by the translocator domain. However, many passengers contain a protease subdomain which may mediate release by autocatalytic processing (16). Alternatively, other outer membrane proteins such as membrane-bound proteases may be involved in processing.
In the course of finding the genes encoding lipolytic enzymes in Pseudomonas putida 3SK, the well-known solvent-tolerant strain, we identified an esterase gene (estA) whose deduced amino acid sequence was identical with that of the outer membrane esterase from P. aeruginosa PAO1 (gene identification number 2218156) (Fig. 1A). EstA is a member of the lipolytic autotransporter enzymes (15, 49). This family of enzymes is characterized by an active site Ser residue that is located very close to the N terminus within the sequence GDSL and the sequence surrounding the residues involved in the catalytic triad (D, S, and H residues) that is different from the analogous residues in the trypsin-like serine proteases (15, 47). However, neither the physiological function of these lipolytic autotransporter enzymes nor their potential for biotechnological applications has been clearly characterized compared with other autotransporter proteins such as immunoglobulin A1 (IgA1) (24), antigen 43 (23), and AIDA-I (41). The translocation of passenger proteins may be related to their size and folding and may be different for each autotransporter ß-domain. Therefore, it is difficult to predict whether a heterologous protein may be secreted by these systems, and this has to be determined case by case. In present study, we investigated the transport function of the EstA C-terminal domain by using analysis of the secondary structure prediction and translational fusions of the periplasmic enzyme ß-lactamase (Bla) with N-terminally truncated EstA C-terminal domains. The expression of the various fusion proteins was monitored, and the surface exposure of the Bla moiety was examined. Based on these results, we predict the sufficient structure necessary for surface expression of the passenger domain and thus propose a possible topological model of the EstA translocator domain in the outer membrane. Finally, we show that the EstA translocator domain-mediated surface display system functionally exports Bla moieties on the surface of Escherichia coli cells in a stable manner without detrimental effects on host cell viability and outer membrane integrity.
![]() View larger version (25K): [in a new window] |
FIG. 1. (A) Schematic representation of the structure of the EstA preprotein. The EstA preprotein is predicted to be composed of a 24-amino-acid signal sequence (SP), the -domain (EstA ) including the catalytic triad, the linking region (LR), and the ß-domain (EstAß). The amino acids indicated in the EstA region show a putative catalytic triad (serine 14, aspartate 286, and histidine 289). The predicted linking region (S307 to G349) is assumed to contain an -helical structure. (B) Schematic representation of the construction of the Bla-EstA fusion proteins. The fusion protein is composed of the Bla signal sequence (BP) and the mature portion of Bla, fused to successively truncated C-terminal portions (numbered 1 to 8) of the EstA. Additional amino acids between Bla and the EstA C-terminal domain which were derived from a restriction enzyme site (NheI) for linking bla and each estA C-terminal region are underlined. Recombinant plasmids pABETU1 to pABETU8 encode the fusion proteins FP1 to FP8, respectively. As a control construct, pABla encodes wild-type Bla in the periplasm.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
To construct the Bla-EstA fusions, the bla gene was amplified by PCR from plasmid pBR322 (5). The PCR fragment was digested with ClaI and NheI, fused to various 3' portions of the gene encoding EstA which differed in length, and inserted into the Tetr gene of plasmid vector pACYC184. The estA 3' regions used to generate constructs employed in this study were amplified from a plasmid preparation of pESTE by PCR. The resulting plasmids contained a genetic fusion of the bla gene with the various EstA C-terminal domains (Fig. 1B); the expression of the corresponding fusion protein is driven by the promoter of the bla gene. As a control, the plasmid (pABla) expressing wild-type Bla in the periplasm was also constructed (Fig. 1B).
The enzymes and related reagents for DNA manipulation used in this study were obtained from New England Biolabs Inc. (Beverley, Mass.), TaKaRa Shuzo Co. (Shiga, Japan), and Sigma Chemical Co. (St. Louis, Mo.). Preparation of plasmids and DNA fragments was performed with QIAGEN kits (QIAGEN). DNA sequencing was carried out by using AmpliTaq DNA polymerase (Perkin-Elmer, Foster City, Calif.) on an ABI PRISM 377 DNA sequencer.
Immunoblot analysis.
The expression of wild-type Bla and fusion proteins was analyzed by the whole-cell lysate of E. coli using Western blots. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the samples were electroblotted onto polyvinylidene difluoride membranes and probed with Bla-specific monoclonal antibody (QED Bioscience Inc., San Diego, Calif.) diluted 1:2,000 in Tris-buffered saline (TBS) (150 mM NaCl, 50 mM Tris-HCl [pH 7.4]) containing 1% gelatin and 0.05% Tween 20. Immunoblots were rinsed three times with TBS containing 0.05% Tween 20 prior to the addition of secondary antibody. Antigen-antibody complexes were visualized by reaction to horseradish peroxidase-linked goat anti-mouse IgG secondary antibody (Sigma) diluted 1:5,000 in TBS. A color reaction of horseradish peroxidase was done according to the manufacturer's instructions (Bio-Rad, Hercules, Calif.).
For whole-cell immunoblots, bacteria grown overnight were harvested from LB agar plates, washed three times with phosphate-buffered saline (PBS) (pH 7.4), and resuspended to an optical density at 600 nm (OD600) of 10.0. Aliquots of 2 µl were applied to a nitrocellulose membrane (Bio-Rad) and allowed to dry completely. Subsequently, the immunodetection was performed as described above.
Protease accessibility.
E. coli cells were collected from the LB agar plates and washed three times with PBS. Subsequently, the bacterial suspension was adjusted to an OD600 of 10.0. Two microliters of trypsin stock solution was added to 200 µl of suspension to yield a final concentration of 50 µg/ml. Suspensions were incubated for 20 min at 37°C, and digestion was stopped by washing the cells three times with PBS. Cells were collected by brief centrifugation and subjected to Western blotting and whole-cell immunoblotting. For the whole-cell immunoblot analysis, 2 µl of bacterial cell suspensions was directly applied to a nitrocellulose membrane (Bio-Rad) and allowed to dry completely before proceeding to next procedure.
Flow cytometry analysis.
For immunofluorescence staining, E. coli cells were collected from the LB agar plates or harvested from LB broth culture and washed three times with PBS. Subsequently, the bacterial suspension was adjusted to an OD600 of 0.5 and resuspended in 1 ml of PBS solution containing 1% bovine serum albumin and Bla-specific monoclonal antibody (1:1,000). Incubation on ice for 1 h was sufficient to allow the primary antibody to bind to its antigen. After being washed three times with PBS, the cells were incubated with the fluorescein isothiocyanate-labeled anti-mouse IgG goat antibody (Sigma) diluted 1:100 in PBS for 1 h on ice, washed five times with PBS, and resuspended in 500 µl of PBS. These cells were examined with a FACScan flow cytometer (Becton Dickinson, Oxnard, Calif.). Samples were illuminated with an argon laser (488 nm), and fluorescence emission was detected at 510 to 530 nm (FL1 channel). For each sample, 50,000 events were counted at a rate between 500 and 1,000 events/s.
Cell viability assay.
The viability of recombinant E. coli cells was estimated by using membrane potential probe bis-(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC4(3); Molecular Probes Inc., Eugene, Oreg.] as previously described (17). Bacterial culture samples were removed from the flasks and resuspended in PBS (approximately 106 to 107 cells/ml) containing 1 µM DiBAC4(3). Cells were allowed to stain at room temperature for 10 min before flow cytometry analysis.
Whole-cell Bla activity assay.
Whole-cell Bla activity was determined by essentially the same method as that described previously (29). E. coli cells expressing surface-displayed Bla were collected from LB agar plates or harvested from LB broth culture and washed three times with PBS. The washed suspension was adjusted to an OD575 of 10.0. Subsequently, 200 µl of this suspension was incubated at room temperature with 50 µl of a penicillin G solution (10 mg/ml). After 10 min, PBS was added to a final volume of 1 ml. After a brief centrifugation at 13,000 x g to remove the cells, the penicillin G content of the supernatant was analyzed by spectrophotometry at 240 nm. As a control, the same assay was performed without incubation for 10 min to obtain normalized
OD values for each experiment.
Nucleotide sequence accession number.
The sequence of the estA gene has been submitted to GenBank under accession number AY676875.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Proteins identified as showing high percent sequence similarity with EstA of P. putida 3SK
|
-helical structure and an additional hypothetical ß-strand together with 11 amphipathic ß-strands which were predicted by Wilhelm et al. (49). Thus, we supposed tentatively that the stretch of amino acids from S307 to G373 of EstA might play a role in ß-barrel formation or in translocation of the passenger domain (Fig. 1A).
Construction of recombinant gene fusions.
To investigate both the possibility of displaying heterologous passenger protein with the EstA translocator domain and the sufficient structure necessary for surface exposure of the N-terminal passenger protein, we constructed a series of fusion proteins which contain Bla and N-terminally truncated EstA C-terminal domains (Fig. 1B). The normally periplasmic enzyme Bla has been frequently employed as a reporter protein for the investigation of surface expression function of anchoring motifs in E. coli (12, 27, 29). Based on a secondary structure prediction using the 3D-PSSM program, the fusion points were designed to give rise to five different lengths of the predicted linking region, resulting in EstA ß3 to EstA ß7. Two additional N-terminal deletions (EstA ß1 and EstA ß2) were set within the predicted ß-domain of EstA, and one more deletion (EstA ß8) was positioned 10 amino acids in front of the predicted linking region. The shortest deletion (EstA ß1) started with A367, which was thought to contain only the 11 amphipathic ß-strands. The resulting plasmids encoded the Bla-EstA fusion proteins, FP1 to FP8, and were designated pABETU1 to pABETU8, respectively (Fig. 1B). As a control, the pABla expressing wild-type Bla in the periplasm was also constructed. All fusion proteins and wild-type Bla were expressed under the control of the native promoter of the bla gene, and the Bla signal sequence was used to ensure the transport of the fusion proteins across the cytoplasmic membrane.
Expression of bla-estA gene fusions.
This set of eight different Bla-EstA fusion proteins and periplasmic Bla were expressed by using E. coli JK321 (dsbA ompT) as a host strain. JK321 is known as a suitable strain for stable display of a cysteine-containing passenger on the surface of E. coli cells via the autotransporter pathway (19, 29, 36). As revealed by the Western blot analysis of total lysates of E. coli JK321 transformants with anti-Bla antibody, all fusion proteins and periplasmic Bla can be detected with expected size (Fig. 2A). However, the expression levels of fusion proteins varied significantly despite the identical background used. The Bla-EstA fusion protein FP8 was expressed at the highest level, followed by FP7 and FP6, comprising smaller portions of EstA C-terminal domain, while very poor expression was observed for FP1 through FP5. Furthermore, to investigate the transport function of the EstA translocator domain, we initially tested the presence of the Bla moiety on the surface of E. coli cells by using whole-cell immunoblot analysis. Physiologically intact recombinant E. coli cells were applied directly to nitrocellulose membrane, and the immunodetection was subsequently performed. As shown in Fig. 2B, E. coli cells expressing the Bla-EstA fusion proteins FP6 through FP8 exhibited the specific antigen-antibody immunoreaction, while cells expressing FP1 through FP5 and periplasmic Bla did not. The color intensity of the whole-cell immunoblot, which indicates the amount of Bla molecules, was found to correlate with the expression level of the fusion proteins and depend on the length of EstA C-terminal domain, as shown by Western blots. This result demonstrates that the fusion proteins FP6 through FP8 appear to be localized in the outer membrane of E. coli exposing the Bla moiety.
![]() View larger version (15K): [in a new window] |
FIG. 2. (A) Expression of fusion proteins in E. coli as assessed by Western blots. Equal amounts of whole-cell lysates of recombinant E. coli JK321 cells corresponding 10 µl of a suspension with an OD600 of 10.0 were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subsequent Western blot analysis with anti-Bla antibody. Lane 1, pACYC184 (vector); lane 2, pABla; lane 3, pABETU1; lane 4, pABETU2; lane 5, pABETU3; lane 6, pABETU4; lane 7, pABETU5; lane 8, pABETU6; lane 9, pABETU7; lane 10, pABETU8. The poorly expressed fusion proteins are indicated by the open arrowheads (lanes 3 to 7), and periplasmic expressed Bla-derived bands are indicated with an arrow (lane 2). (B) Surface exposure of fusion proteins assessed by whole-cell immunoblots. Equal amounts of recombinant E. coli JK321 cell suspensions were applied directly to nitrocellulose membrane and subsequently subjected to immunodetection analysis. Each lane is the same as those described for panel A. (C) Surface exposure of fusion proteins in various E. coli strains assessed by whole-cell immunoblots. Equal amounts of recombinant E. coli cell suspensions were applied directly to nitrocellulose membrane and subsequently subjected to immunodetection analysis.
|
Probing the surface localization of Bla.
Surface expression of the Bla moiety was further verified by protease accessibility. Because externally added macromolecules cannot penetrate through the outer membrane, extracellular protease treatment of physiologically intact cells has been used to provide evidence for the surface localization of target proteins. Trypsin treatment of intact JK321(pABETU6), JK321(pABETU7), and JK321(pABETU8) led to the disappearance of the Bla-EstA fusion proteins FP6, FP7, and FP8, respectively, as assessed by Western blots (Fig. 3A). In contrast, Bla located in the periplasm was not susceptible to protease treatment. Consistently, whole-cell immunoblot analysis clearly indicates that the Bla moiety of these fusion proteins is exposed on the surface of E. coli (Fig. 3B). Thus, the Bla-EstA fusion proteins FP6 through FP8 were expected to contain a complete translocator domain which is necessary for the surface expression of the N-terminally fused passenger domain.
![]() View larger version (16K): [in a new window] |
FIG. 3. Protease accessibility of fusion proteins assessed by (A) Western blots and (B) whole-cell immunoblots. Samples were prepared and analyzed as described in the legend of Fig. 2. Tryptic digestion of physiologically intact cells was performed as described in Materials and Methods.
|
![]() View larger version (21K): [in a new window] |
FIG. 4. (A) FACS histograms of recombinant E. coli cells to determine surface localization of Bla. The E. coli cell line harboring pACYC184 (vector) was used as the negative control, and the corresponding histogram (dotted line) was superimposed on results (solid line) with E. coli expressing periplamsic Bla (pABla) or Bla-EstA fusion proteins (indicated recombinant plasmid). (B) Mean fluorescence intensities of E. coli cells expressing periplasmic Bla and Bla-EstA fusion proteins.
|
![]() View larger version (13K): [in a new window] |
FIG. 5. Growth kinetics and viability of E. coli cells expressing the Bla-EstA fusion proteins and periplasmic Bla. The E. coli cells harboring pACYC184 (vector) (), pABla ( ), and pABETU8 ( ) were grown in LB broth, and the viability of each recombinant E. coli cell suspension (open symbols) was estimated by using DiBAC4(3) staining (determined in duplicate without significant variation).
|
In order to find out whether the surface-exposed Bla shows enzymatic activity, penicillin G was employed as the substrate since it does not readily diffuse through the outer membrane (38) and thus has been frequently used for determination of surface-displayed Bla activity (12, 29). As shown in Fig. 6, the Bla-EstA fusion protein FP8-expressing E. coli cells showed whole-cell Bla activity, and this whole-cell activity was significantly influenced by cultivation conditions. In contrast, E. coli cells expressing periplasmic Bla (pABla) have only negligible levels of Bla activity in this experimental condition (data not shown). Lowering the growth temperature of FP8-expressing E. coli cells resulted in a significant increase of whole-cell Bla activity as shown previously by others (12, 29). Interestingly, FP8-expressing E. coli cells grown on solid LB medium showed much higher Bla activity than the cells grown in liquid LB medium. Consistently, the cells grown on solid LB medium showed the higher mean fluorescence intensity, indicating that more Bla moieties were displayed on the cell surface, as determined by FACS analysis (data not shown). Also, when FP8-expressing E. coli cells were grown in the presence of ampicillin, the whole-cell Bla activity was found to increase.
![]() View larger version (13K): [in a new window] |
FIG. 6. Whole-cell Bla activity of E. coli cells expressing the Bla-EstA fusion proteins. The E. coli cell line harboring pABETU8 was grown on an LB agar plate (solid) or in LB broth (liquid) at indicated temperatures with (open bars) and without (filled bars) ampicillin. Whole-cell Bla activities are shown as the mean values, representing the results of five independent experiments, which are calculated for the amounts of bacteria present in 1 ml of a suspension with an OD575 of 1.0 ( 2.5 x 109 CFU). One unit of Bla activity is defined as the amount of enzyme that hydrolyzes 1 µmol of penicillin G per min.
|
|
|
|---|
From the data shown, we demonstrated that the translocator domain both necessary and sufficient for surface expression could be limited to the amino acids encompassing L297 through to F622 in EstA and that the expression levels of each fusion protein were significantly dependent on the length of the predicted linking region. Although EstA ß6 and EstA ß7 domains were capable of translocating the passenger protein through the outer membrane, their targeting to the outer membrane was partly impaired and/or needed extended time for stable ß-barrel structure compared with the EstA ß8 domain. We therefore assume that a region between L297 and E317 could somehow contribute to ß-barrel function, such as facilitating the interaction with the outer membrane and/or enhancing the stability of the ß-barrel structure in the membrane. These results, taken together with the secondary structure prediction, led us to propose a possible topological model, depicted in Fig. 7. In this model, 12 ß-strands, which consist of 11 amphipathic ß-strands and one more hypothetical ß-strand, together with an
-helical structure are supposed to form a ß-barrel. A recent investigation of the autotransporter NalP from Neisseria meningitidis revealed that a single translocator domain, which is composed of a 12-stranded ß-barrel and an N-terminal
-helix, is sufficient for the transport of the N-terminal passenger domain (40). An additional stretch of amino acids from L297 to E317 together with an
-helical structure are assumed to serve as a linking region for efficient surface expression and for stable membrane structure. It has been shown that many autotransporter proteins, such as the IgA protease of Neisseria (24), the VirG protein of Shigella (46), the AIDA-I protein of E. coli (36), and the Hia adhesion of Haemophilus influenzae (45), require a linking region for their proper folding in the outer membrane and the translocation of passenger protein on the surface.
![]() View larger version (58K): [in a new window] |
FIG. 7. Possible topological model of the organization of the EstA ß-domain in the outer membrane. The C-terminal ß-domain of EstA might be composed of 12 amphipathic ß-strands (pentagons) and one -helical structure (cylinder). Eleven amphipathic ß-strands (solid lines) are clearly predicted by the 3D-PSSM program within the C-terminal region Y374 to F622 as shown by Wilhelm et al. (49), while one more ß-strand and an -helix are hypothetical (dotted line). The first amino acid residues of the N-terminally truncated EstA ß-domains are indicated by arrows.
|
Besides host cell viability, the biological activity of the surface-exposed heterologous passengers should also be considered. The enzymatic activity of the surface-exposed Bla was shown by whole-cell penicillin G hydrolysis, and this whole-cell activity significantly varied with cultivation conditions including the growth temperature, the type of medium, and the presence of substrate, ampicillin. However, the surface-expressed fusion proteins FP6 through FP8 seem to have the Bla activity in the periplasmic space because the surface-exposed Bla by itself does not seem to completely degrade ampicillin molecules present in the liquid medium before they reach the periplasm by diffusion. This Bla activity probably arises from the translocation intermediates whose C-terminal ß-domain is inserted in the outer membrane, and the N-terminal Bla passengers exist in the periplasmic side with the partially folded state. Previous reports demonstrated that the folding of the passenger domain takes place in the periplasm before, or at least simultaneously with, translocation through the outer membrane (6, 39). Alternatively, the residual Bla activity in the periplasm, resulting from proteolytic degradation of fusion proteins, might protect the penicillin binding proteins from inactivation by ampicillin.
A successful surface display system should satisfy several requirements. First, it should be compatible with the foreign moiety and consequently guarantee the biological activity of surface-exposed passenger protein. Second, a maximum number of fully exposed foreign moieties per cell should be presented. Third, the expression of the surface-exposed passenger moiety should occur without compromising cell viability or the outer membrane integrity. From our data described here, the EstA translocator domain-based surface display of heterologous passenger protein mostly satisfies these requirements. Since P. putida is a well-known solvent-tolerant strain and has been used in environmental biotechnology (44) as well as in biotechnological production processes in two-phase systems as a whole-cell biocatalyst (31), we are trying to employ this EstA translocator domain-mediated surface display system for the development of whole-cell biocatalysts using P. putida as a host strain.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»